Haijing Wu
- Immunology top 1%
- Molecular Biology top 5%
- Rheumatology top 0.5%
- Cancer Research top 2%
- Oncology top 5%
- Topics
- T-cell and B-cell Immunology (52 papers)Systemic Lupus Erythematosus Research (46 papers)Immune Cell Function and Interaction (44 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Haijing Wu
118 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Immunology 2.0k
- Molecular Biology 1.5k
- Rheumatology 1.0k
- Cancer Research 663
- Oncology 557
Countries citing papers authored by Haijing Wu
This map shows the geographic impact of Haijing Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haijing Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haijing Wu more than expected).
Fields of papers citing papers by Haijing Wu
This network shows the impact of papers produced by Haijing Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haijing Wu. The network helps show where Haijing Wu may publish in the future.
Co-authorship network of co-authors of Haijing Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Haijing Wu. A scholar is included among the top collaborators of Haijing Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haijing Wu. Haijing Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | Cold and hot tumors: from molecular mechanisms to targeted therapybreakdown → | 174 |
| 3 | 5 | |
| 4 | 1 | |
| 5 | 12 | |
| 6 | 7 | |
| 7 | 2 | |
| 8 | 6 | |
| 9 | 43 | |
| 10 | 19 | |
| 11 | 15 | |
| 12 | 34 | |
| 13 | 56 | |
| 14 | 15 | |
| 15 | 46 | |
| 16 | 34 | |
| 17 | 20 | |
| 18 | 67 | |
| 19 | 31 | |
| 20 | 45 |
About Haijing Wu
Haijing Wu is a scholar working on Immunology, Rheumatology and Cancer Research, having authored 120 papers that have together received 4.0k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (52 papers), Systemic Lupus Erythematosus Research (46 papers) and Immune Cell Function and Interaction (44 papers). The work is most often cited by research in Immunology (2.0k citations), Rheumatology (1.0k citations) and Cancer Research (663 citations). Haijing Wu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Ming Zhao, Qianjin Lu, Qianjin Lu, Christopher Chang, Yongjian Chen, Lina Tan, Hai Long, Di Long, Christopher Chang and Duo Li. Their work appears in journals such as Nature, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.